Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient CareRelease Date:Quality Improvement Support for the Professions Senegal PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology China Improving cancer care in patients with metastatic breast cancerRelease Date:Quality Improvement Oncology Kazakhstan An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)Release Date:Education Inflammation & Immunology All Improving Health Equity in IBD through Disparities ResearchRelease Date:Research Inflammation & Immunology All Emerging Science in the Management of Acute Myeloid LeukemiaRelease Date:Education Oncology All Addressing Systemic Drivers of Racial Health InequitiesRelease Date:Quality Improvement Health Equity USA Diversity in Postmarketing Drug Safety SurveillanceRelease Date:Research Patient Safety USA Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient EducationRelease Date:Education Oncology Ghana, Rwanda Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-PacificRelease Date:Education Rare Disease All Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates 2023 Inflammatory Bowel Disease (IBD) Fellowship – IndiaRelease Date:Fellowship Inflammation & Immunology India Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)Release Date:Education Rare Disease All 2023/2024 Global NASH ASPIRERelease Date:Research Internal Medicine All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East AsiaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationQuality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and OpportunitiesRelease Date:Education Hospital USA Improving Care for Patients with Multiple MyelomaRelease Date:Education Oncology USA HRRm Testing in Metastatic Prostate CancerRelease Date:Education Oncology All Advancing Oncology Education for Healthcare ProfessionalsRelease Date:Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology All Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)Release Date:Education Oncology All Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan AfricaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationReview Process: Expert Review PanelQuality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe Improving the Care of Persons Living with Metastatic Breast CancerRelease Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditionsRelease Date:Education Inflammation & Immunology Canada Improving Advanced Prostate Cancer Management in Latin AmericaEducation Oncology Argentina, Brazil, Chile, Colombia, Mexico Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient CareResearch Oncology USA Addressing Knowledge Gaps in Ulcerative Colitis (UC) CareRelease Date:Education Inflammation & Immunology USA 2024 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the HRRm Testing Gap in Prostate Cancer PatientsRelease Date:Quality Improvement Oncology Canada Improving the care and outcomes of residents of Canada living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Improving the Equity and Quality of Cancer Care in ColombiaRelease Date:Partner: The Colombian Association of Oncology and Hematology (ACHO)Quality Improvement Oncology Colombia Enhancing Molecular Testing for Metastatic Colorectal Cancer PatientsRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement Oncology Canada Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial InfectionsRelease Date:Education Hospital All IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)Release Date:Partner: Crohn's & Colitis FoundationQuality Improvement Inflammation & Immunology USA 2024 Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Rare Disease All Junior Investigator Global ATTR Cardiac Amyloidosis ResearchRelease Date:Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain Reducing Barriers to Optimal Clinical Care in Breast CancerRelease Date:Quality Improvement Oncology Spain Quality Improvement Grants to Improve Identification and Management of Patients with ATTR AmyloidosisRelease Date:Quality Improvement Rare Disease Spain Advances in Migraine ManagementRelease Date:Education Internal Medicine USA 2024 IM US Headache Medicine FellowshipRelease Date:Fellowship Internal Medicine USA RSV Infection and RSV Maternal Immunization in Area of Obstetrics and GynecologyRelease Date:Education Vaccines Japan Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous ThromboembolismEducation Internal Medicine All Bolstering Clinical Research Capacity to Address China Health Equity DisparitiesRelease Date:Education Health Equity China Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease USA